Hansen, A. R., Borgwardt, L., Rasmussen, Å. K., Godballe, C., Godballe, C., Poulsen, M. M., . . . Rossing, M. (2021). Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Hansen, Anna Reimer, et al. Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Hansen, Anna Reimer, et al. Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.